Monte Rosa Therapeutics, Inc. (GLUE)
NASDAQ: GLUE · Real-Time Price · USD
22.39
-0.45 (-1.97%)
At close: Jan 26, 2026, 4:00 PM EST
22.25
-0.14 (-0.63%)
After-hours: Jan 26, 2026, 7:45 PM EST
Monte Rosa Therapeutics Market Cap
Monte Rosa Therapeutics has a market cap or net worth of $1.77 billion as of January 26, 2026. Its market cap has increased by 342.35% in one year.
Market Cap
1.77B
Enterprise Value
1.42B
1-Year Change
342.35%
Ranking
Category
Stock Price
$22.39
Market Cap Chart
Since the IPO on June 24, 2021, Monte Rosa Therapeutics's market cap has increased from $845.31M to $1.77B, an increase of 109.77%. That is a compound annual growth rate of 17.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 1.81B | 77.16% |
| Dec 31, 2025 | 1.02B | 139.48% |
| Dec 31, 2024 | 426.37M | 50.74% |
| Dec 29, 2023 | 282.85M | -23.21% |
| Dec 30, 2022 | 368.32M | -61.22% |
| Dec 31, 2021 | 949.65M | 12.34% |
| Jun 24, 2021 | 845.31M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vericel | 1.91B |
| Sionna Therapeutics | 1.89B |
| Ardelyx | 1.89B |
| Nurix Therapeutics | 1.88B |
| Pharvaris | 1.82B |
| Biohaven | 1.79B |
| Immunocore Holdings | 1.77B |
| Syndax Pharmaceuticals | 1.76B |